IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN PERU

被引：0
|
作者：
Lopez-Cabra, C. [1 ]
Rodriguez, A. D. [2 ]
Mayorga, Mogollon W. [2 ]
Chavez, M. A. [3 ]
Patino, A. [1 ]
Herran, S. E. [1 ]
Marrugo, R. [1 ]
机构：
[1] Bayer, Bogota, Cun, Colombia
[2] Numeris, Bogota, Colombia
[3] Bayer, San Jose, Cun, Costa Rica
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE423
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [11] Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Moura-Neto, Jose A.
    Ronco, Claudio
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11):
  • [12] A Prediction Model on Incident End-Stage Kidney Disease (ESKD) among Individuals with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)
    Lin, Yilu
    Shao, Hui
    Anderson, Amanda H.
    Fonseca, Vivian
    Batuman, Vecihi
    Shi, Lizheng
    DIABETES, 2022, 71
  • [13] Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Bakris, George L.
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Nowack, Christina
    Schloemer, Patrick
    Joseph, Amer
    Filippatos, Gerasimos
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23): : 2219 - 2229
  • [14] Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes Reply
    Bakris, George L.
    Agarwal, Rajiv
    Filippatos, Gerasimos
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11):
  • [15] Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown
    Fu, Edouard L.
    Kutz, Alexander
    Desai, Rishi J.
    KIDNEY INTERNATIONAL, 2023, 103 (01) : 30 - 33
  • [16] Finerenone in patients with chronic kidney disease and type 2 diabetes mellitus
    Wanner, C.
    Nitschmann, S.
    INTERNIST, 2021, 62 (05): : 577 - 580
  • [17] RESOURCE AND COST BURDEN OF CHRONIC KIDNEY DISEASE (CKD) STAGE 3-5 NOT ON DIALYSIS (ND) IN THE UNITED KINGDOM (UK): TYPE 2 DIABETES (T2D) AND WITHOUT DIABETES
    Marx, Steven
    Petrilla, Allison
    Filipovic, Ivana
    Lee, Won Chan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 395 - 395
  • [18] Finerenone and Kidney Outcomes in Patients with CKD and T2D: Results from FIDELITY
    Bakris, George L.
    Ruilope, Luis M.
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Fried, Linda F.
    Roy-Chaudhury, Prabir
    Sarafidis, Pantelis
    Ahlers, Christiane
    Joseph, Amer
    Brinker, Meike D.
    Lawatscheck, Robert
    Agarwal, Rajiv
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B6 - B6
  • [19] Level of Glycemic Control in Type 2 Diabetes (T2D) Patients with Established Cardiovascular Disease (eCVD) or Chronic Kidney Disease (CKD) Prescribed an SGLT2i
    Iglay, Kristy
    Bansal, Neha
    Gulati, Tania
    Hannachi, Hakima
    Fernandes, Gail
    Rajpathak, Swapnil
    DIABETES, 2019, 68
  • [20] Diabetic Kidney Disease (DKD) in UK Patients With Type 2 Diabetes (T2D)
    Ruzafa, Javier Cid
    Paczkowski, Rosirene
    Boye, Kristina S.
    Di Tanna, Gian Luca
    Sheetz, Matthew J.
    Donaldson, Robert
    Breyer, Matthew D.
    Neasham, David
    Voelker, James R.
    DIABETES, 2013, 62 : A397 - A397
12345